Results 261 to 270 of about 242,415 (401)

Melatonin alleviates oxidative stress induced damage in human iPSCs harboring mtDNA 3243A>G mutation via MAPK pathway. [PDF]

open access: yesStem Cell Res Ther
Pu Z   +12 more
europepmc   +1 more source

Galcanezumab reduces trigeminal nociception and is effective in preclinical models of migraine and trigeminal autonomic cephalalgias

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to assess the therapeutic efficacy of galcanezumab in preclinical models of migraine and cluster headache and to determine potential shared trigeminovascular mechanisms of action. Galcanezumab is a humanized monoclonal antibody that binds to the neuropeptide calcitonin gene‐related peptide ...
Marta Vila‐Pueyo   +3 more
wiley   +1 more source

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary While migraine headaches can be hard to predict, some patients believe headaches are connected to the moon‘s phases. Our research showed that migraine attacks were 34% more likely to occur during the new moon than during the full moon.
Alexander Yoo   +5 more
wiley   +1 more source

Long‐Term Dynamic in vitro System for Investigating Rat Pineal Melatonin Secretion [PDF]

open access: bronze, 1991
Z. Rékési   +4 more
openalex   +1 more source

Can atogepant be a preventive treatment for cluster headache?—Insights from a case series

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Cluster headache (CH) is a disabling primary headache disorder with limited therapeutic options. Calcitonin gene‐related peptide (CGRP) is known to be involved in CH pathophysiology; however, except for galcanezumab (300 mg) in episodic CH, anti‐CGRP monoclonal antibodies did not reduce CH attacks in randomized clinical trials. Atogepant is an
Catarina Serrão   +3 more
wiley   +1 more source

Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas

open access: yesCellular and Molecular Life Sciences, 2017
R. Reiter   +5 more
semanticscholar   +1 more source

A Series of Personalized Melatonin Supplement Interventions for Poor Sleep: Feasibility Randomized Crossover Trial for Personalized N-of-1 Treatment. [PDF]

open access: yesJMIR Form Res
Butler MJ   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy